Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Richardson, P; Soiffer, RJ; Antin, JH; Jin, Z; Kurtzberg, J; Martin, PL; Steinbach, G; Murray, KF; Vogelsang, GB; Chen, A; Krishnan, A; Kernan, NA; Avigan, D; Spitzer, TR; Warren, D; Revta, C; Wei, LJ; Iacobelli, M; McDonald, GB; Guinan, EC

Published Date

  • November 16, 2006

Published In

Volume / Issue

  • 108 / 11

Start / End Page

  • 17A - 18A

Published By


  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 48th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • Orlando, FL

Conference Start Date

  • December 9, 2006

Conference End Date

  • December 12, 2006